Establishment of transplantable porcine tumor cell lines derived from MHC-inbred miniature swine.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMC 2190613)

Published in Blood on August 16, 2007

Authors

Patricia S Cho1, Diana P Lo, Krzysztof J Wikiel, Haley C Rowland, Rebecca C Coburn, Isabel M McMorrow, Jennifer G Goodrich, J Scott Arn, Robert A Billiter, Stuart L Houser, Akira Shimizu, Yong-Guang Yang, David H Sachs, Christene A Huang

Author Affiliations

1: Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.

Articles cited by this

Statins and cancer prevention. Nat Rev Cancer (2005) 4.12

Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation (1976) 3.41

Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev (1999) 2.83

Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol (1984) 2.62

Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer (2004) 2.20

Modeling metastasis in vivo. Carcinogenesis (2004) 2.02

Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest (2000) 1.74

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood (2002) 1.68

Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep (1982) 1.51

Regeneration of the surface glycoproteins of a transplantable mouse tumor cell after treatment with neuraminidase. Proc Natl Acad Sci U S A (1972) 1.51

Validating cancer drug targets. Nature (2006) 1.43

Characterization of monoclonal antibodies directed against swine leukocytes. Vet Immunol Immunopathol (1986) 1.42

Histocompatible miniature swine: an inbred large-animal model. Transplantation (2003) 1.33

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. Biol Blood Marrow Transplant (1999) 1.28

Multiple myeloma biology: lessons from the 5TMM models. Immunol Rev (2003) 1.27

Large animal models and gene therapy. Eur J Hum Genet (2006) 1.24

Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation (2006) 1.21

Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells. J Exp Med (1988) 1.17

Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest (2006) 1.06

Solid tumor models for the assessment of different treatment modalities: II: rapid, intermediate, and slow growing transplantable rat hepatomas. Life Sci (1976) 1.01

Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplantation (1999) 1.01

Establishment and characterization of human B cell precursor-leukemia cell lines. Leuk Res (1998) 0.98

Further studies on the effect of neuraminidase on tumor cell transplantability. Tissue Antigens (1971) 0.97

History and classification of human leukemia-lymphoma cell lines. Leuk Lymphoma (1998) 0.94

Transplantability and antigenicity of two sublines of the TA3 tumor. J Immunol (1973) 0.93

Preclinical modeling of combination treatments: fantasy or requirement? Ann N Y Acad Sci (2005) 0.91

Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase. J Immunol (1973) 0.91

Posttransplantation lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood (2001) 0.90

The p53 story: layers of complexity. Carcinogenesis (2005) 0.89

Adoptive T cell therapy of solid cancers. Cancer Immunol Immunother (2005) 0.89

The Second International Swine CD Workshop. Vet Immunol Immunopathol (1996) 0.89

Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine. Transplantation (2004) 0.89

Monoclonal precipitating antibodies to porcine immunoglobulin M. Vet Immunol Immunopathol (1985) 0.89

Development of a large animal model for lung tumors. J Vasc Interv Radiol (2002) 0.86

Analyses of mAb reactive with porcine CD8. Vet Immunol Immunopathol (1994) 0.86

Immunobiology of a spontaneously regressive tumor, the canine transmissible venereal sarcoma (review). Anticancer Res (1988) 0.84

Summary of workshop findings for antibodies reacting with porcine T-cells and activation antigens: results from the Second International Swine CD Workshop. Vet Immunol Immunopathol (1998) 0.83

Modeling disease in the mouse: lessons from DNA damage response and cell cycle control genes. J Cell Biochem (2006) 0.83

Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res (2000) 0.83

Analysis of monoclonal antibodies reactive with the porcine CD2 antigen. Vet Immunol Immunopathol (1994) 0.83

Analyses of monoclonal antibodies reacting with porcine CD3: results from the Second International Swine CD Workshop. Vet Immunol Immunopathol (1998) 0.83

Monoclonal antibodies putatively identifying porcine B cells. Vet Immunol Immunopathol (1998) 0.82

CD11/CD18 panel report for swine CD workshop. Vet Immunol Immunopathol (1994) 0.81

Summary of workshop findings for porcine B-cell markers. Vet Immunol Immunopathol (2001) 0.81

Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model. Am J Transplant (2004) 0.81

Monoclonal antibodies putatively recognising activation and differentiation antigens. Vet Immunol Immunopathol (2001) 0.80

Characterization of monoclonal antibodies recognizing immunoglobulin kappa and lambda chains in pigs by flow cytometry. Vet Immunol Immunopathol (2001) 0.79

Mouse models of efficient and inefficient anti-tumor immunity, with emphasis on minimal residual disease and tumor escape. Cancer Immunol Immunother (2005) 0.79

Comparative studies on cell lines established from normal and radiation-exposed miniature swine. In Vitro (1979) 0.78

Methods in metastasis research. A critical review. Invasion Metastasis (1983) 0.78

Summary of observations on transplantable tumors of the rat thyroid gland. Biochimie (1999) 0.77

Use of CD9 expression to enrich for porcine hematopoietic progenitors. Exp Hematol (2002) 0.77

Some observations on an induced adaptation in a transplantable tumor. Exp Cell Res (1965) 0.77

Tumor immunity. Transplant Proc (1977) 0.76

Experimental induction of porcine leukemia. Bibl Haematol (1970) 0.76

Articles by these authors

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42

Characterization of human atherosclerosis by optical coherence tomography. Circulation (2002) 5.04

Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol (2002) 4.94

Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation (2003) 4.69

T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell (2008) 4.32

Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med (2004) 3.63

Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med (2004) 3.58

Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood (2006) 2.94

Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med (2004) 2.91

Ventral hernias in morbidly obese patients: a suggested algorithm for operative repair. Obes Surg (2013) 2.78

Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol (2009) 2.70

Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A (2004) 2.54

Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Cent Rep (2004) 2.53

Transcription-coupled events associating with immunoglobulin switch region chromatin. Science (2003) 2.50

CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45

Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30

Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood (2011) 2.24

Proliferative glomerulonephritis with monoclonal immunoglobulin G3κ deposits in association with parvovirus B19 infection. Hum Pathol (2012) 2.16

Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol (2004) 2.03

A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol (2004) 2.02

Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med (2011) 1.97

The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med (2003) 1.96

Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol (2012) 1.95

Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J Immunol (2008) 1.92

Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J Cell Biol (2004) 1.85

Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates. Transplantation (2004) 1.82

Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. J Am Coll Cardiol (2007) 1.82

UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients. Int J Clin Oncol (2009) 1.82

Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Proc Natl Acad Sci U S A (2007) 1.80

Thrombotic microangiopathic glomerulopathy in human decay accelerating factor-transgenic swine-to-baboon kidney xenografts. J Am Soc Nephrol (2005) 1.79

Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol (2006) 1.77

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation (2002) 1.75

Will the pig solve the transplantation backlog? Annu Rev Med (2002) 1.74

Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol (2002) 1.71

ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol (2010) 1.69

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood (2002) 1.68

Characterization of atherosclerotic plaques by laser speckle imaging. Circulation (2005) 1.66

Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood (2008) 1.60

Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc Natl Acad Sci U S A (2007) 1.58

alpha1,3-Galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation (2005) 1.56

RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice. Mol Ther (2009) 1.55

Isolation and species distribution of staphylococci from animal and human skin. J Vet Med Sci (2002) 1.52

Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant (2010) 1.52

Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab (2005) 1.48

Xenogeneic thymus transplantation in a pig-to-baboon model. Transplantation (2003) 1.47

Attenuation of phagocytosis of xenogeneic cells by manipulating CD47. Blood (2006) 1.44

Immunogenicity of umbilical cord tissue derived cells. Blood (2007) 1.42

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2004. A 75-year-old woman with acute onset of chest pain followed by fever. N Engl J Med (2004) 1.40

A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. The Journal of Experimental Medicine. 1973. 138: 1289-1304. J Immunol (2011) 1.39

Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation (2003) 1.36

Thrombotic microangiopathy associated with humoral rejection of cardiac xenografts from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Am J Pathol (2008) 1.36

Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J Virol (2004) 1.35

No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes (2004) 1.35

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation. Biol Blood Marrow Transplant (2003) 1.35

Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol (2002) 1.35

Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol (2003) 1.34

Histocompatible miniature swine: an inbred large-animal model. Transplantation (2003) 1.33

HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2013) 1.29

Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects. Eur J Endocrinol (2004) 1.29

A model for personalized in vivo analysis of human immune responsiveness. Sci Transl Med (2012) 1.27

Modeling chronic lung allograft rejection in miniature swine. Transplantation (2002) 1.26

Mixed chimerism and transplantation tolerance. Transplantation (2004) 1.26

Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs. Nucleic Acids Res (2006) 1.26

Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons. Xenotransplantation (2004) 1.26

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25

Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest (2005) 1.24

Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J Immunol (2010) 1.22

Stable multilineage chimerism without graft versus host disease following nonmyeloablative haploidentical hematopoietic cell transplantation. Transplantation (2006) 1.21

Method for hemoglobin A(1c) measurement based on peptide analysis by electrospray ionization mass spectrometry with deuterium-labeled synthetic peptides as internal standards. Clin Chem (2003) 1.21

Development of a diphtheria toxin based antiporcine CD3 recombinant immunotoxin. Bioconjug Chem (2011) 1.20

Induction of human T-cell tolerance to porcine xenoantigens through mixed hematopoietic chimerism. Blood (2004) 1.19

Homeostatic expansion and phenotypic conversion of human T cells depend on peripheral interactions with APCs. J Immunol (2010) 1.18

Split tolerance to a composite tissue allograft in a swine model. Transplantation (2003) 1.18

Induction of tolerance to heart transplants by simultaneous cotransplantation of donor kidneys may depend on a radiation-sensitive renal-cell population. Transplantation (2003) 1.18

Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen. Am J Transplant (2004) 1.17

Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010. Clin Exp Nephrol (2013) 1.17

Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood (2009) 1.16

Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization. Stem Cells (2002) 1.14

An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant (2007) 1.12

Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12

Combination treatment with donor-specific transfusions and cyclosporine a induces long-term survival of cardiac allografts in miniature Swine. Transplantation (2005) 1.12